Sort
51,593 grants matching “hepatitis”
Antiviral agents directed to novel targets in the adenovirus proteinase
$781,650Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2011 · AI
NIDA Clinical Trials Network: Big South/West Node
$781,644Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2022 · DA
Immune response to COVID-19 vaccine in HIV infected men and women
$781,490Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$781,354Rohit Loomba · University Of California, San Diego · U01 · FY2021 · AA
Studies of Atomic Bomb Survivors
$781,251Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Spectinomycin analogs for NTM infections
$781,206Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2024 · AI
Identification and validation of targets for therapeutic intervention in rare diseases of intermediary metabolism
$781,186Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2017 · TR
Deciphering the role of ddhCTP in viperin-related functions
$781,139Tyler L Grove · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Bupropion for smoking cessation during pregnancy
$781,117Gary D Hankins · University Of Texas Med Br Galveston · R01 · FY2013 · DA
Mechanisms of repeated control of acute hepatitis C infection in humans
$781,044Andrea L Cox · Johns Hopkins University · U19 · FY2020 · AI
Therapeutic Strategies and Molecular Correlates in Aggressive B-cell Lymphomas
$780,978Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis
$780,961Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · AI
Monkey Alcohol Tissue Research Resource (MATRR)
$780,903Kathleen A Grant · Oregon Health & Science University · R24 · FY2012 · AA
Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
$780,790Charles M. Rice · Rockefeller University · R01 · FY2025 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$780,775Justin Richard Bailey · Johns Hopkins University · R01 · FY2025 · AI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy
$780,422Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · R24 · FY2014 · OD
Human Genetic determinants of HBV recovery
$780,411David L Thomas · Johns Hopkins University · R01 · FY2024 · AI
Sphingosine kinase 2 in sexual dimorphism of hepatocellular carcinoma
$780,346Christopher D Green · Virginia Commonwealth University · R01 · FY2025 · CA
YAP signaling in the pathogenesis of NAFLD in people living with HIV
$780,234Raymond T Chung · Massachusetts General Hospital · R01 · FY2024 · DK
Research to Improve and Standardize Marmoset Nutrition and Dietary Husbandry
$780,224Suzette D Tardif · Texas Biomedical Research Institute · R24 · FY2017 · OD
Development of polymeric synthetic biomaterial IP-001 to potentiate asystemic immunotherapy of hepatocellular carcinoma via thermal ablation
$780,148Siu Kit Lam · Immunophotonics, Inc. · R44 · FY2024 · CA
Understanding the Regional Ecology of a Future HIV Vaccine
$780,044Dolores Albarracin · University Of Pennsylvania · R01 · FY2023 · MH
TION OF CHOLECYSTOKININ-B RECEPTOR-POSITIVE STEM CELLS INDUCES HEPATIC CARCINOGENESIS
$780,000Georgetown University · · FY2021 · Defense Health Agency
Integrated heart-liver-vascular systems for drug testing in human health and dise
$779,987Gordana Vunjak-Novakovic · Columbia Univ New York Morningside · UH2 · FY2012 · EB
The Epidemiology of the Weiss Cohort Project
$779,861Stanley H Weiss · Rbhs-New Jersey Medical School · R01 · FY2020 · DA